DIFFERENTIATING from current expression systems (animal cells, yeasts, bacteria):
►NINKARAK®: recombinant immunotoxins and fusion proteins ('recalcitrant', 'difficult‑to‑express' proteins) for short‑term applications in immuno‑oncology
►ALGAVAX®: thermostable subunit vaccines, alongwith vegetal adjuvants
►ALGAPHARM®: nasal, oral, pulmonary, topical delivery, innovative galenic pharmacology by controlled cellular fragmentation of microalgae
►ALGATHERAPEUTICS®: in the longer run, with the aim to manufacture any other type of recombinant proteins in commercial quantities at a reduced cost.